SCHEMBL593261

SCHEMBL593261

c1ccc2c(c1)ccc1c(-c3cccc4c3ccc3ccccc34)cccc12

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 3/20 0.78
ALDH1A1 P00352 7/20 0.67
HSD17B10 Q99714 5/20 0.67
TSHR P16473 3/20 0.67
CYP2A6 P11509 3/20 0.67
TDP1 Q9NUW8 2/20 0.67
CYP1A2 P05177 5/20 0.55
HPGD P15428 4/20 0.55
HIF1A Q16665 3/20 0.55
CYP1B1 Q16678 1/20 0.55
THRB P10828 1/20 0.55
PAX8 Q06710 1/20 0.54
MAPK1 P28482 3/20 0.50
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX12 P18054 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29769915 1.00 HPRT1 (0.78) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL29445992 1.00 HPRT1 (0.78) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30021505 0.97 HPRT1 (0.74) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30021848 0.97 HPRT1 (0.74) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30103588 0.97 HPRT1 (0.74) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL442130 0.97 HPRT1 (0.74) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL25402768 0.95 HPRT1 (0.70) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30103767 0.95 HPRT1 (0.70) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
Fluoride SCHEMBL28869243 0.95 HPRT1 (0.70) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL30332462 0.95 HPRT1 (0.70) HPRT1ALDH1A1HSD17B10TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534484-B2 Process for preparing dimeric phosphazene derived BrØnsted acids STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2026-01-27 US claimed
EP-4200308-B1 PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2025-09-10 EP claimed
CN-114106050-B Compact chiral environment biphenanthrene skeleton chiral phosphoric acid and preparation method and application thereof 华东理工大学 2024-01-12 CN claimed
US-20230406870-A1 PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2023-12-21 US claimed
CN-117243931-A Application of bletilla striata biphenanthrene C in preparation of medicines for inhibiting tumor metastasis 成都中医药大学 2023-12-19 CN claimed
EP-4200308-A1 PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS Studiengesellschaft Kohle gGmbH (DE) 2023-06-28 EP claimed
WO-2022073803-A1 PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2022-04-14 WO claimed
US-11084834-B2 Chiral phosphoramidimidates and derivatives thereof STUDIENGESELLSCHAFT KOHLE MBH (DE) 2021-08-10 US claimed
EP-3344639-B1 CHIRAL PHOSPHORAMIDIMIDATES AND DERIVATIVES THEREOF STUDIENGESELLSCHAFT KOHLE MBH (DE) 2020-06-24 EP claimed
US-20180339999-A1 CHIRAL PHOSPHORAMIDIMIDATES AND DERIVATIVES THEREOF STUDIENGESELLSCHAFT KOHLE MBH (DE) 2018-11-29 US claimed
EP-2802560-B1 PROCESS FOR THE ASYMMETRIC OXIDATION OF ORGANIC COMPOUNDS WITH PEROXIDES IN THE PRESENCE OF A CHIRAL ACID CATALYST STUDIENGESELLSCHAFT KOHLE MBH (DE) 2018-03-07 EP claimed
EP-2802561-B1 CHIRAL IMIDODIPHOSPHATES AND DERIVATIVES THEREOF STUDIENGESELLSCHAFT KOHLE MBH (DE) 2017-07-26 EP claimed
EP-3138845-A1 CHIRAL PHOSPHORAMIDIMIDATES AND DERIVATIVES THEREOF Studiengesellschaft Kohle MbH (DE) 2017-03-08 EP claimed
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP claimed
EP-2615083-A1 Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst Studiengesellschaft Kohle mbH (DE) 2013-07-17 EP claimed
EP-2615098-A1 Chiral imidodiphosphates and derivatives thereof Studiengesellschaft Kohle mbH (DE) 2013-07-17 EP claimed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US claimed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US claimed
US-12534484-B2 Process for preparing dimeric phosphazene derived BrØnsted acids STUDIENGESELLSCHAFT KOHLE GGMBH (DE) 2026-01-27 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180339999-A1 CHIRAL PHOSPHORAMIDIMIDATES AND DERIVATIVES THEREOF PLCB3, PIN1, PLCD1 HPRT1 304/4885ALDH1A1 3621/4885HSD17B10 4410/4885
US-20230406870-A1 PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS PHOSPHO1, BRPF1, BRD9 HPRT1 93/4885ALDH1A1 3679/4885HSD17B10 4557/4885
US-11084834-B2 Chiral phosphoramidimidates and derivatives thereof PLCB3, PIN1, PLCD1 HPRT1 304/4885ALDH1A1 3621/4885HSD17B10 4410/4885
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 HPRT1 273/4885ALDH1A1 220/4885HSD17B10 2763/4885
US-12534484-B2 Process for preparing dimeric phosphazene derived BrØnsted acids HAT1, LBR, CD79B HPRT1 1410/4885ALDH1A1 4176/4885HSD17B10 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.